|
|
 |
 |
Corporate Overview · History · Team · Partners
History
KliniPharm is a young and innovative biopharmaceutical company founded on the ideals of thousands of years, harnessing natural remedies to fight disease and promote health and well-being. We are especially proud of and are inspired by our German-Greek heritage, dating back to the father of medicine and first naturopath, Hippocrates, and numerous German homeopaths, including Samuel Hahnemann and his protégés. KliniPharm strives to merge cutting edge science with centuries of accumulated expertise in natural medicine, with a particular focus on medicinal properties of marine flora.
 |
| 1993 – Dr. Wolfgang and Maria Schatton found KliniPharm GmbH, seeking to advance research on natural compounds and homeopathic remedies. With roots in one of the oldest pharmacies in Frankfurt, Germany, KliniPharm combines the experience of generations in naturopathy and homeopathy with biopharmaceutical technology, laying the foundation for future scientific research endeavors. |
|
 |
| 1996 – KliniPharm is commissioned by the German Ministry of Education and Research to investigate the potential medicinal application of novel substances found in marine sponges. |
 |
|
|
1996-1999 – In collaboration with
academic institutions, KliniPharm scientists successfully
identify more than ten sponge species out of
hundreds with promising bioactivity profiles. |
 |
|
|
| 1998 – In alliance with the Department of Chemistry and Pharmaceutical Sciences of the University of Frankfurt, KliniPharm establishes a Ph.D. program in pharmaceutical technology and enrolls its first student. |
|
|
| 2000 – KliniPharm is awarded the SPONGE Grant from
the European Commission’s Research Directorate-General to investigate the potential commercializability of marine sponges for pharmaceutical applications. |
 |
|
|
| 2000-2003 – KliniPharm expands research collaborations to multiple scientific institutes throughout Europe and develops methodologies enabling the isolation of commercializable amounts of active compounds from marine sponges for the first time. |
 |
|
|
| 2001 – KliniPharm begins to develop product prototypes using nanoparticles and liposomes as drug delivery vehicles. |
|
|
| 2001 – Tobias Schatton
joins KliniPharm as a partner. |
|
|
| 2003 – Maria Schatton, CEO of KliniPharm, receives the Economic Award from the German-Hellenic Economic Association for her integrative role in furthering marine research and advancing commercial relations between Germany and Greece. |
 |
|
|
| 2004 – KliniPharm receives DIN EN ISO certification for establishing an effective quality management system to ensure the best safety and quality of our products and for continually meeting regulatory requirements of European surveillance authorities. |
 |
|
|
2005 – KliniPharm is awarded the SPONGES Grant from
the European Commission’s Research Directorate-General to develop large-scale production capabilities of marine sponge biomass. |
|
|
|
2005-2007 – KliniPharm continues to expand collaboration agreements with scientific institutes and corporate partners throughout Europe and expands environmentally sustainable sponge aquacultures.
|
|
|
2008 – KliniPharm launches its novel
eleana™ skin care and wellness line in test markets in Germany. eleana™ is the first marine-based product line successfully developed from academic grants and sponsorship from the European Comission. |
 |
|
|
| 2010 – KliniPharm, in collaboration with its partnered compounding pharmacy, launches novel hormonal rebalancing creams, which incorporate the company’s patented vesigel® transdermal delivery technology. |
 |
|
|
| 2011 – Klinipharm continues to undergo expansion efforts for its elena™ and hormonal rebalancing products and additional product developments are underway. |
|
Copyright ©2002-2012 KliniPharm GmbH, Eschenheimer Tor 3, 60318 Frankfurt, Germany
Terms of Use | Privacy Policy | Created by Citrus Design |
|
|
|
|
